Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO -14.27% Operating Cash Flow per Share is $0.00 as of Jun. 2026. The stock has 1 warning sign investors should review. Among 157 Medical Diagnostics & Research companies, Invitro International ranks worse than 636942.04% on this metric.
Invitro International's operating cash flow per share for the
three
months ended in Jun. 2026 was $0.00.
Invitro International's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Invitro International's Operating Cash Flow per Share or its related term are showing as below:
During the past 2 years, Invitro International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 36.70% per year. The lowest was 34.30% per year. And the median was 35.50% per year.
IVRO's 3-Year OCF Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 13.6 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Invitro International Operating Cash Flow per Share Related Terms
Invitro International Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Invitro International's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International Operating Cash Flow per Share Chart
IVRO vs IDTA, FUNI, BIAF: Operating Cash Flow per Share Comparison
For the Diagnostics & Research subindustry, Invitro International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Price-to-Operating-Cash-Flow vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Invitro International's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.00 mean?
Invitro International (IVRO) has a Operating Cash Flow per Share of $0.00 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #999999 out of 157 companies in the Medical Diagnostics & Research industry.
Is Invitro International's Operating Cash Flow per Share too high?
Invitro International's current Operating Cash Flow per Share is $0.00. Based on the distribution chart, Invitro International ranks #999999 out of 157 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Invitro International's Operating Cash Flow per Share compare to IDTA and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #999999 out of 157 companies for Operating Cash Flow per Share. This places Invitro International in the lower half of its industry. The industry median Operating Cash Flow per Share is 13.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Diagnostics & Research company?
The median Operating Cash Flow per Share among Medical Diagnostics & Research companies is 13.60, based on 157 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Operating Cash Flow per Share is 13.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Operating Cash Flow per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Fairly Valued. The stock's GF Value™ is $0.06, compared to a current price of $0.06 — trading right at its estimated fair value. The current Operating Cash Flow per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Invitro International (IVRO), the current Operating Cash Flow per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
